Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001564590-22-020163
Filing Date
2022-05-13
Accepted
2022-05-13 17:16:37
Documents
13

Document Format Files

Seq Description Document Type Size
1 DEFR14A acad-defr14a_20220607.htm DEFR14A 3111294
2 GRAPHIC gafwvlmribyd000020.jpg GRAPHIC 98642
3 GRAPHIC gafwvlmribyd000001.jpg GRAPHIC 26428
4 GRAPHIC gafwvlmribyd000004.jpg GRAPHIC 21563
5 GRAPHIC gafwvlmribyd000090.jpg GRAPHIC 13811
6 GRAPHIC gafwvlmribyd000061.jpg GRAPHIC 182874
7 GRAPHIC gafwvlmribyd000003.jpg GRAPHIC 5236
8 GRAPHIC gafwvlmribyd000093.jpg GRAPHIC 742055
9 GRAPHIC gafwvlmribyd000002.jpg GRAPHIC 39580
10 GRAPHIC gafwvlmribyd000092.jpg GRAPHIC 758189
11 GRAPHIC gafwvlmribyd000006.jpg GRAPHIC 11677
12 GRAPHIC gafwvlmribyd000029.jpg GRAPHIC 306353
13 GRAPHIC gafwvlmribyd000005.jpg GRAPHIC 28407
  Complete submission text file 0001564590-22-020163.txt   6190358
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-50768 | Film No.: 22924024
SIC: 2834 Pharmaceutical Preparations